prednisone has been researched along with Lymph Node Metastasis in 189 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "CMFVP chemotherapy, either alone or in combination with tamoxifen, has not been shown to be superior to tamoxifen alone in the treatment of postmenopausal women with node-positive, ER-positive, operable breast cancer." | 9.07 | Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study. ( Abeloff, MD; Costanzi, JJ; Cruz, AB; Farrar, WB; Green, S; Jewell, WR; Metch, B; Minton, JP; Osborne, CK; Rivkin, SE, 1994) |
| "Four hundred forty-one women with operable breast cancer with histologically positive axillary nodes were randomized to receive either combination cyclophosphamide (60 mg/m2 orally everyday for 1 year); fluorouracil (300 mg/m2 intravenously [IV] weekly for 1 year); methotrexate (15 mg/m2 IV weekly for 1 year); vincristine (0." | 9.06 | Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study. ( Athens, J; Constanzi, JJ; Gad-el-Mawla, N; Glucksberg, H; Green, S; Hoogstraten, B; Maloney, T; Metch, B; Osborne, CK; Rivkin, SE, 1989) |
| "A randomized clinical trial was performed to determine if the addition of hormonal therapy with tamoxifen to a combination chemotherapy regimen was superior to the chemotherapy alone for adjuvant treatment of premenopausal women after mastectomy for node-positive breast cancer." | 9.06 | Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer. ( Cullinan, SA; Everson, LK; Fitzgibbons, RG; Foley, JF; Hagen, JB; Ingle, JN; Krook, JE; Martin, JK; Wieand, HS; Wold, LE, 1989) |
| "A prospectively controlled randomized trial to compare the adjuvant efficacy of 12 cycles of cyclophosphamide, methotrexate, fluorouracil, prednisone, and tamoxifen (CMFPT) followed by observation or a total of 5 years of continuous tamoxifen versus four cycles of CMFPT followed by observation in postmenopausal women with operable node-positive breast cancer was started by the Eastern Cooperative Oncology Group (ECOG) in 1982." | 9.06 | Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study. ( Falkson, G; Falkson, HC; Gillchrist, KW; Gray, R; Harris, JE; Tormey, DC; Wolberg, WH, 1990) |
| "5 mg daily) to an adjuvant cyclophosphamide-methotrexate-5-fluorouracil chemotherapy regimen was investigated in a randomized trial of 505 pre- and perimenopausal patients with operable breast cancer and one to three axillary lymph node metastases (Ludwig Breast Cancer Study I)." | 9.05 | A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. ( , 1985) |
| "After mastectomy, 265 postmenopausal patients with node-positive breast cancer were stratified according to pathologic nodal status and estrogen-receptor (ER) status and randomized to receive either 12 cycles of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP), or CMFP plus tamoxifen (CMFPT), or observation alone." | 9.05 | Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study. ( Bennett, JM; Carbone, PP; Cummings, F; Falkson, G; Kalish, LA; Olson, JE; Taylor, SG; Tormey, DC, 1985) |
| "Five-hundred thirty-one eligible women with hormone receptor-negative, node-positive breast cancer were randomized to receive either 1 year of therapy with CMFVP or 20 weeks of therapy with four 5-week courses of treatment with 5-FU, doxorubicin, cyclophosphamide, and methotrexate (FAC-M)." | 5.08 | Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study. ( Abeloff, MD; Budd, GT; Green, S; Hahn, R; Harris, J; Martino, S; O'Bryan, RM; O'Sullivan, J; Rinehart, JJ; Tormey, D, 1995) |
| "A randomised trial has previously been repeated in which 437 women with node positive breast cancer received either a 12-week chemohormonal regimen consisting of cyclophosphamide, methotrexate, fluorouracil, vincristine, prednisone, adriamycin and tamoxifen or 36 weeks of CMFVP." | 5.07 | The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation. ( Abu-Zahra, H; Arnold, A; Bramwell, V; Findlay, B; Gent, M; Goodyear, MD; Levine, MN; Skillings, J, 1992) |
| "CMFVP chemotherapy, either alone or in combination with tamoxifen, has not been shown to be superior to tamoxifen alone in the treatment of postmenopausal women with node-positive, ER-positive, operable breast cancer." | 5.07 | Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study. ( Abeloff, MD; Costanzi, JJ; Cruz, AB; Farrar, WB; Green, S; Jewell, WR; Metch, B; Minton, JP; Osborne, CK; Rivkin, SE, 1994) |
| "To determine if prolonged adjuvant treatment (2 years v 1 year) with combination chemotherapy (cyclophosphamide, methotrexate, fluorouracil [5-FU], vincristine, and prednisone [CMFVP]) in poor-prognosis breast cancer patients (estrogen receptor [ER]-negative, stage II to IIIA) would result in improved disease-free and overall survival rates." | 5.07 | One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study. ( Altman, SJ; Costanzi, JJ; Green, S; Jewell, WR; Metch, B; Minton, JP; O'Bryan, RM; Osborne, CK; Rivkin, SE, 1993) |
| "Between 1978 and 1981, 463 evaluable postmenopausal patients 65 years of age or younger with operable breast cancer and metastases in axillary lymph nodes were entered in Ludwig Breast Cancer Study III (Ludwig III) and randomly allocated to receive chemoendocrine therapy with cyclophosphamide, methotrexate, 5-fluorouracil, low-dose continuous prednisone, and tamoxifen (CMFp + T) for 12 monthly cycles, or endocrine therapy alone with prednisone and tamoxifen (p + T) for 1 year, or no adjuvant treatment after mastectomy (observation)." | 5.06 | A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. ( Gelber, RD; Goldhirsch, A, 1986) |
| "Eight hundred eighteen premenopausal or perimenopausal breast cancer patients with axillary node metastases were treated with adjuvant chemotherapy (CMF) with or without endocrine treatment (prednisone, oophorectomy) in two concurrent prospective trials." | 5.06 | Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses. ( Castiglione, M; Gelber, RD; Goldhirsch, A, 1988) |
| "Three hundred ten patients with Stage II or Stage III breast cancer were entered on an adjuvant protocol consisting of a combination of 5-fluorouracil, doxorubicin, cyclophosphamide, vincristine, and prednisone (FACVP)." | 5.06 | Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs. ( Ames, FC; Buzdar, AU; Fraschini, G; Holmes, FA; Hortobagyi, GN; Hug, V; Kau, S; Marcus, C; Martin, RG; Smith, TL, 1988) |
| "Four hundred forty-one women with operable breast cancer with histologically positive axillary nodes were randomized to receive either combination cyclophosphamide (60 mg/m2 orally everyday for 1 year); fluorouracil (300 mg/m2 intravenously [IV] weekly for 1 year); methotrexate (15 mg/m2 IV weekly for 1 year); vincristine (0." | 5.06 | Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study. ( Athens, J; Constanzi, JJ; Gad-el-Mawla, N; Glucksberg, H; Green, S; Hoogstraten, B; Maloney, T; Metch, B; Osborne, CK; Rivkin, SE, 1989) |
| "A randomized clinical trial was performed to determine if the addition of hormonal therapy with tamoxifen to a combination chemotherapy regimen was superior to the chemotherapy alone for adjuvant treatment of premenopausal women after mastectomy for node-positive breast cancer." | 5.06 | Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer. ( Cullinan, SA; Everson, LK; Fitzgibbons, RG; Foley, JF; Hagen, JB; Ingle, JN; Krook, JE; Martin, JK; Wieand, HS; Wold, LE, 1989) |
| "A prospectively controlled randomized trial to compare the adjuvant efficacy of 12 cycles of cyclophosphamide, methotrexate, fluorouracil, prednisone, and tamoxifen (CMFPT) followed by observation or a total of 5 years of continuous tamoxifen versus four cycles of CMFPT followed by observation in postmenopausal women with operable node-positive breast cancer was started by the Eastern Cooperative Oncology Group (ECOG) in 1982." | 5.06 | Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study. ( Falkson, G; Falkson, HC; Gillchrist, KW; Gray, R; Harris, JE; Tormey, DC; Wolberg, WH, 1990) |
| "The Southwest Oncology Group in a prospective randomized study compared one year of adjuvant combination chemotherapy with continuous CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone) to two years of intermittent L-phenylalanine mustard (L-PAM) in women with operable breast cancer with histologically positive axillary lymph nodes." | 5.05 | Adjuvant therapy of breast cancer: the Southwest Oncology Group experience. ( Athens, JW; Costanzi, JJ; Foulkes, MA; Glucksberg, H; Knight, WA; O'Bryan, RM; Rivkin, SE; Stephens, RL, 1983) |
| "After mastectomy, 265 postmenopausal patients with node-positive breast cancer were stratified according to pathologic nodal status and estrogen-receptor (ER) status and randomized to receive either 12 cycles of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP), or CMFP plus tamoxifen (CMFPT), or observation alone." | 5.05 | Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study. ( Bennett, JM; Carbone, PP; Cummings, F; Falkson, G; Kalish, LA; Olson, JE; Taylor, SG; Tormey, DC, 1985) |
| "5 mg daily) to an adjuvant cyclophosphamide-methotrexate-5-fluorouracil chemotherapy regimen was investigated in a randomized trial of 505 pre- and perimenopausal patients with operable breast cancer and one to three axillary lymph node metastases (Ludwig Breast Cancer Study I)." | 5.05 | A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. ( , 1985) |
| "Adjuvant therapy after total mastectomy and axillary clearance in postmenopausal women with breast cancer and axillary node metastasis was assessed; chemo-endocrine therapy (cyclophosphamide, methotrexate, fluorouracil, prednisone, and tamoxifen; CMFp + T) was compared with endocrine therapy (prednisone and tamoxifen; p + T), and with no adjuvant treatment in 463 patients aged less than or equal to 65 years." | 5.05 | Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis. ( , 1984) |
| "The management of primary breast carcinoma has undergone a successful change during the decade of the 1970s." | 3.75 | Multimodal treatment of primary breast carcinoma: analysis of accomplishments and problem areas. ( DeVita, VT; Henney, JE; Weiss, RB, 1981) |
| "We determined plasma levels of c-erbB-2 in 79 stages II and III breast cancer patients who received cyclophosphamide, methotrexate, and flourouracil (CMF)/cyclophosphamide, methotrexate, fluorouracil, vincristine, and prednisone (CMFVP) chemotherapy." | 3.70 | Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy. ( Das Gupta, TK; Hieken, TJ; Marler, KC; McDermott, JH; Mehta, RR; Patel, MK; Wild, LD, 1998) |
| "In 56 patients with disseminated or locally advanced breast cancer it was attempted to reach a state of no evidence of disease by a remission induction regime containing prednisone, 5-fluorouracil, methotrexate, doxorubicin and vincristine." | 3.68 | Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer. ( de Vries, EG; Dolsma, WV; Mulder, NH; Mulder, PO; Sleijfer, DT; van der Ploeg, E; Willemse, PH, 1993) |
| "Seventeen patients with mycosis fungoides and lymph node involvement were treated with polycytostatic courses consisting of cyclophosphamide, vincristin (Oncovin) and prednisone (COP)." | 3.67 | Systemic polychemotherapy in patients with mycosis fungoides and lymph node involvement: a follow-up study of 17 patients. ( Sentis, HJ; Van Vloten, WA; Willemze, R, 1985) |
| "A series of 41 patients at the MGH who received 5-drug chemotherapy, cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisone, (CMF VP) as adjuvant to surgical treatment of operable breast cancer with 4 or more positive axillary nodes is compared to an analogous group of patients treated with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) reported by Bonadonna et al." | 3.66 | 5-drug adjuvant chemotherapy for breast cancer. ( Carey, RW; Halpern, E; Kaufman, S; Kelley, RM; Lew, RA; Sohier, WD; Weitzman, SA, 1979) |
| "One hundred women with primary breast cancer with 4 or more metastatic axillary nodes were treated for 9 months postoperatively with vincristine, prednisone, cyclophosphamide, methotrexate, and fluorouracil (VPCMF)." | 3.66 | Adjuvant chemotherapy of breast cancer. ( Cooper, RG; Glidewell, O; Holland, JF, 1979) |
| " The aim of the SYNERGY trial was to investigate the effect of custirsen in combination with docetaxel and prednisone on overall survival in patients with metastatic castration-resistant prostate cancer." | 2.84 | Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial. ( Bergman, AM; Blumenstein, B; Chi, KN; de Bono, JS; Ferrero, JM; Feyerabend, S; Gleave, M; Gravis, G; Higano, CS; Jacobs, C; Merseburger, AS; Mukherjee, SD; Reeves, J; Saad, F; Stenzl, A; Zalewski, P, 2017) |
| "Retroperitoneal fibrosis is a rare disease characterized by chronic nonspecific inflammation, which leads to clinical compression manifestations of retroperitoneal organs especially ureter." | 2.82 | Idiopathic retroperitoneal fibrosis with endometrial cancer: a case report and literature review. ( Han, J; He, H; Li, J; Qiao, J; Si, M; Yao, Y; Zhang, K, 2022) |
| "AT-101 was tolerable but did not extend OS when combined with DP in mCRPC; a potential benefit was observed in high-risk patients." | 2.77 | Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer. ( Berry, WR; Brookes, M; Burke, JM; Caton, JR; Fleming, MT; Galsky, MD; Holmlund, JT; Hutson, TE; Karlov, P; Leopold, L; Matveev, V; Sonpavde, G; Wood, BA, 2012) |
| "Histologic slides from selected breast cancer cases entered on node-negative Eastern Cooperative Oncology Group trials were assigned grades." | 2.70 | Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192). ( Allred, DC; Dressler, LG; Gray, R; Hatfield, AK; Martino, S; Page, DL; Robert, NJ; Wood, WC, 2001) |
| "Men with metastatic prostate cancer (n = 161) were randomized to receive either daily prednisone alone or mitoxantrone (every 3 weeks) plus prednisone." | 2.69 | Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone. ( Ernst, DS; Neville, AJ; Osoba, D; Tannock, IF, 1999) |
| "Postoperative women with breast cancer but without histopathological evidence of metastases to the axillary lymph nodes or clinical evidence of metastases were studied." | 2.67 | Chemotherapy versus observation in high-risk node-negative breast cancer patients. ( Cooper, MR; Eudey, L; Falkson, G; Gilchrist, KW; Mansour, EG; Osborne, CK; Shatila, AH; Tormey, DC, 1992) |
| "In 1978 the International (Ludwig) Breast Cancer Study Group (IBCSG) initiated four complementary randomized controlled clinical trials to evaluate the roles of chemo-endocrine combinations or endocrine therapy alone in specific populations defined by risk (for pre- and perimenopausal patients) or by age (for postmenopausal patients)." | 2.67 | The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up. ( Castiglione-Gertsch, M; Collins, J; Cortes-Funes, H; Forbes, J; Gelber, RD; Goldhirsch, A; Hacking, A; Johnsen, C; Lindtner, J; Rudenstam, CM, 1994) |
| "Adjuvant therapy trials in breast cancer have grown steadily more complex since 1971, when the first long-term adjuvant trial in the United States was initiated." | 2.65 | Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: preliminary results--the ECOG experience. ( Carbone, PP, 1983) |
| "Women with breast carcinoma and four or more involved ipsilateral axillary lymph nodes were randomly assigned to receive an induction course and 2 yr of maintenance chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF, 150 patients), CMF plus vincristine and prednisone (CMFVP, 166 patients), or chemoimmunotherapy with CMF plus the methanol extraction residue of BCG (CMF-MER, 85 patients)." | 2.65 | A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer. ( Falkson, G; Falkson, HC; Glidewell, OJ; Henry, PH; Holland, JF; Leone, LA; Perloff, M; Tormey, DC; Weinberg, VE; Weiss, RB, 1983) |
| "Dermatomyositis is an inflammatory autoimmune condition that has also been associated with malignancy." | 2.47 | Multicentric reticulohistiocytosis with dermatomyositis-like features: a more common disease presentation than previously thought. ( Fett, N; Liu, RH, 2011) |
| "In hormone-sensitive metastatic prostate cancer, androgen deprivation represents the first-line treatment." | 2.44 | Management of metastatic prostate cancer: the crucial role of geriatric assessment. ( Chaladaj, A; Droz, JP, 2008) |
| "Burkitt tumors are malignant lymphoblastic lymphomas occurring predominantly in Africa in children and young adults and involving in many cases the intestinal tract; these tumors occur rather seldom outside Africa." | 2.36 | [Isolated tumor of the rectum as primary manifestation of Burkitt lymphoma (author's transl)]. ( Döhnert, G; Feltkamp, H; Lang, R; Mies, R; Mödder, B; Stock, W; Thiele, KG, 1981) |
| "Cabazitaxel is a treatment of metastatic castration-resistant prostate cancer (mCRPC) after docetaxel failure." | 1.51 | Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort. ( Balestra, A; Droz-Perroteau, C; Fizazi, K; Fourrier-Reglat, A; Guiard, E; Joly, F; Jove, J; Lacueille, C; Lamarque, S; Moore, N; Oudard, S; Rouyer, M; Tubach, F, 2019) |
| "We report a case of metastatic papillary thyroid carcinoma and undifferentiated nonkeratinizing nasopharyngeal carcinoma to the same cervical lymph node following chemotherapy for mantle cell lymphoma." | 1.42 | Case report: metastases from thyroid and nasopharyngeal carcinomas in the same lymph node following chemotherapy for mantle cell lymphoma. ( Joshua Liao, D; Luo, D; Wang, Z; Xiao, H, 2015) |
| "Primary breast lymphoma is a rare disease entity." | 1.37 | [Primary lymphoma of breast: a clinicopathologic and prognostic study of 40 cases]. ( Fu, L; Fu, XL; Jin, ZJ; Lang, RG; Liu, FF; Lü, AJ; Wang, XF; Wang, Y; Yang, H, 2011) |
| "The treatment strategies of Hodgkin's lymphoma (HL) are different according to clinical stage and risk factors, yet the optimal treatment strategy remains unclear." | 1.34 | [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases]. ( Hu, DS; Hu, S; Song, QB; Tan, WY; Wei, L; Zeng, FY; Zhou, LQ, 2007) |
| "Of 6 patients who developed recurrence, 3 (7." | 1.33 | [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease]. ( Han, JZ; Jin, J; Li, YX; Liu, XF; Liu, YP; Song, YW; Wang, SL; Wang, WH; Yu, ZH; Zhou, LQ, 2006) |
| "Treatment strategies in Hodgkin's disease have an impact on different risk factors." | 1.32 | Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90. ( Dieckmann, K; Heinzl, H; Hofmann, J; Pötter, R; Schellong, G; Wagner, W, 2003) |
| "Patients with breast cancer and a high number of involved axillary lymph nodes have a poor prognosis, despite adjuvant chemotherapy." | 1.29 | Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes. ( de Graaf, H; de Vries, EG; Dolsma, WV; Mulder, NH; Mulder, PO; Sleijfer, DT; Smit Sibinga, CT; van der Graaf, WT; van der Ploeg, E; Willemse, PH, 1994) |
| "Metastatic bronchioloalveolar carcinoma is an aggressive disease that is associated with a poor prognosis, similar to metastatic adenocarcinoma of the lung." | 1.28 | Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: comparison of clinical manifestations, chemotherapeutic responses, and prognosis. ( Eagan, RT; Feldman, ER; Schaid, DJ, 1992) |
| "Stage II patients with breast carcinoma who had undergone lumpectomy." | 1.28 | Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial. ( Allen, S; Bosworth, H; Budman, D; Lehrman, D; Lichtman, SM; Schulman, P; Vinciguerra, V; Weiselberg, L; Weiss, R, 1991) |
| "Seventeen patients with advanced stage Hodgkin's disease who relapsed or failed to respond to multiple regimens of combination chemotherapy (mostly Mechlorethamine, Vincristine, Procarbarzine, Prednisone and Adriamycin, Bleomycin, Vinblastine, Dacarbazine) were treated with accelerated hyperfractionated total lymphoid irradiation (TLI) and high-dose chemotherapy followed by autologous bone marrow transplantation (AuBMT)." | 1.28 | Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease. ( Clarkson, B; Fuks, Z; Gulati, S; Shank, B; Yahalom, J, 1989) |
| "The rate of recurrence formation was found to be in a significant correlation with general symptoms, age, size of the largest cluster of involved lymph nodes, combination of drugs and type of consolidating therapy." | 1.27 | [Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy]. ( Kharatishvili, ZV; Kolygin, BA, 1983) |
| "Most of the children with Hodgkin's disease diagnosed before or during puberty can be cured with chemotherapy alone, and thus will not suffer from the damaging late effects of radiotherapy." | 1.27 | Treatment of Hodgkin's disease in children with or without radiotherapy. ( Behrendt, H; Van Bunningen, BN; Van Leeuwen, EF, 1987) |
| "Nineteen patients with Hodgkin's disease who relapsed primarily in nodal sites after intensive combination chemotherapy were retreated with wide-field radiation therapy alone or with additional chemotherapy between January 1971 and December 1984." | 1.27 | Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy. ( Mauch, P; Rosenthal, D; Skarin, A; Tarbell, N; Weinstein, H, 1987) |
| "Three patients with metastatic breast carcinoma who had untreated locally advanced primary tumors were treated initially with combination chemotherapy followed by hygienic mastectomy." | 1.26 | Mastectomy as an adjunct to combination chemotherapy. ( Aisner, J; Elias, EG; Morris, D; Wiernik, PH, 1978) |
| "The meningeal metastasis was treated by surgery and irradiation with orbital penetration; the lymph nodes were irradiated, and COPP polychemotherapy was given to treat the rest of the metastatic localizations." | 1.26 | [Extraskeletal manifestations of unusual localization in a case of myeloma (author's transl)]. ( Caballero, O; Martínez, J; Marty, ML; Mayans, J; Sanz, MA, 1979) |
| "Dermatomyositis is a disease of unknown etiology characterized by muscle weakness and associated with a variety of cutaneous lesions." | 1.26 | Dermatomyositis and Malignancy. ( Vanderploeg, DE, 1977) |
| " While earlier results suggested that adjuvant chemotherapy is especially effective in premenopausal women, newer studies and analyses indicate that appropriate dosage and consistent administration of chemotherapy are of decisive importance." | 1.26 | [Results of, and indications for adjuvant chemotherapy in breast cancer]. ( Brunner, KW; Goldhirsch, A; Joss, R; Sonntag, RW; Tschopp, L, 1981) |
| "A patient with nodular histiocytic lymphoma was treated with bleomycin; she later developed interstitial pneumonitis documented by lung biopsy." | 1.25 | Reversible interstitial pneumonitis associated with low dose bleomycin. ( Kardinal, CG; O'Neill, TJ; Tierney, LM, 1975) |
| "Autopsy revealed a malignant lymphoma of mixed histiocytic-lymphocytic type involving mainly the mesenteric lymph nodes, but also affecting the jejunal mucosa, liver, spleen and extraabdominal lymph nodes." | 1.25 | Abdominal lymphoma with alpha-heavy chain disease. ( Golouh, R; Plesnicar, S; Sumi-Kriznik, T, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 82 (43.39) | 18.7374 |
| 1990's | 38 (20.11) | 18.2507 |
| 2000's | 33 (17.46) | 29.6817 |
| 2010's | 31 (16.40) | 24.3611 |
| 2020's | 5 (2.65) | 2.80 |
| Authors | Studies |
|---|---|
| Si, M | 1 |
| Zhang, K | 1 |
| Li, J | 1 |
| He, H | 1 |
| Yao, Y | 1 |
| Han, J | 1 |
| Qiao, J | 1 |
| Choi, ME | 1 |
| Yang, HJ | 1 |
| Won, CH | 1 |
| Chang, SE | 1 |
| Lee, MW | 1 |
| Choi, JH | 1 |
| Lee, WJ | 1 |
| Rouyer, M | 1 |
| Oudard, S | 1 |
| Joly, F | 1 |
| Fizazi, K | 2 |
| Tubach, F | 1 |
| Jove, J | 1 |
| Lacueille, C | 1 |
| Lamarque, S | 1 |
| Guiard, E | 1 |
| Balestra, A | 1 |
| Droz-Perroteau, C | 1 |
| Fourrier-Reglat, A | 1 |
| Moore, N | 1 |
| Colomba, E | 1 |
| Marret, G | 1 |
| Baciarello, G | 1 |
| Lavaud, P | 1 |
| Massard, C | 1 |
| Loriot, Y | 1 |
| Albiges, L | 1 |
| Carton, E | 1 |
| Alexandre, J | 1 |
| Huillard, O | 1 |
| Culine, S | 1 |
| Remolina-Bonilla, YA | 1 |
| Jimenez-Franco, B | 1 |
| Lam, ET | 1 |
| Bourlon, MT | 1 |
| Haas, NB | 1 |
| LaRiviere, MJ | 1 |
| Buckingham, TH | 1 |
| Cherkas, Y | 1 |
| Calara-Nielsen, K | 1 |
| Foulk, B | 1 |
| Patel, J | 1 |
| Gross, S | 1 |
| Smirnov, D | 1 |
| Vaughn, DJ | 1 |
| Amaravadi, R | 1 |
| Wellen, KE | 1 |
| Savitch, SL | 1 |
| Majmundar, KJ | 1 |
| Black, TA | 1 |
| Yee, SS | 1 |
| He, M | 1 |
| Min, EJ | 1 |
| Long, Q | 1 |
| Jones, JO | 1 |
| Pal, SK | 1 |
| Carpenter, EL | 1 |
| Kanno, H | 1 |
| Ishida, K | 1 |
| Yamada, W | 1 |
| Nishida, T | 1 |
| Takahashi, N | 1 |
| Mochizuki, K | 1 |
| Mizuno, Y | 1 |
| Matsuyama, K | 1 |
| Takahashi, T | 1 |
| Seishima, M | 2 |
| Zheng, SM | 1 |
| Zhou, DJ | 1 |
| Chen, YH | 1 |
| Jiang, R | 1 |
| Wang, YX | 1 |
| Zhang, Y | 1 |
| Xue, HL | 1 |
| Wang, HQ | 1 |
| Mou, D | 1 |
| Zeng, WZ | 1 |
| Kodama, S | 1 |
| Kurose, K | 1 |
| Mukai, T | 1 |
| Morita, Y | 1 |
| Gallamini, A | 1 |
| Tarella, C | 1 |
| Viviani, S | 2 |
| Rossi, A | 2 |
| Patti, C | 1 |
| Mulé, A | 1 |
| Picardi, M | 1 |
| Romano, A | 1 |
| Cantonetti, M | 1 |
| La Nasa, G | 1 |
| Trentin, L | 1 |
| Bolis, S | 1 |
| Rapezzi, D | 1 |
| Battistini, R | 1 |
| Gottardi, D | 1 |
| Gavarotti, P | 1 |
| Corradini, P | 1 |
| Cimminiello, M | 1 |
| Schiavotto, C | 1 |
| Parvis, G | 1 |
| Zanotti, R | 1 |
| Gini, G | 1 |
| Ferreri, AJM | 1 |
| Viero, P | 1 |
| Miglino, M | 1 |
| Billio, A | 1 |
| Avigdor, A | 1 |
| Biggi, A | 1 |
| Fallanca, F | 1 |
| Ficola, U | 1 |
| Gregianin, M | 1 |
| Chiaravalloti, A | 1 |
| Prosperini, G | 1 |
| Bergesio, F | 1 |
| Chauvie, S | 1 |
| Pavoni, C | 1 |
| Gianni, AM | 1 |
| Rambaldi, A | 1 |
| Amber, KT | 1 |
| Valdebran, M | 1 |
| Lu, Y | 1 |
| De Feraudy, S | 1 |
| Linden, KG | 1 |
| Sasse, S | 1 |
| Goergen, H | 1 |
| Plütschow, A | 1 |
| Böll, B | 1 |
| Eichenauer, DA | 1 |
| Fuchs, M | 1 |
| Behringer, K | 1 |
| Zijlstra, JM | 1 |
| Greil, R | 1 |
| Markova, J | 1 |
| Topp, MS | 1 |
| Meissner, J | 1 |
| Neubauer, A | 1 |
| Baues, C | 1 |
| Engert, A | 1 |
| Borchmann, P | 1 |
| von Tresckow, B | 1 |
| Lee, E | 1 |
| Kim, TM | 1 |
| Lim, Y | 1 |
| Jeon, YK | 1 |
| Go, H | 1 |
| Kim, CW | 1 |
| Heo, DS | 1 |
| Aggarwal, R | 1 |
| Halabi, S | 1 |
| Kelly, WK | 1 |
| George, D | 1 |
| Mahoney, JF | 1 |
| Millard, F | 1 |
| Stadler, WM | 1 |
| Morris, MJ | 1 |
| Kantoff, P | 1 |
| Monk, JP | 1 |
| Carducci, M | 1 |
| Small, EJ | 1 |
| Berroa de la Rosa, E | 1 |
| Casadiego Matarranz, L | 1 |
| Aparicio Duque, R | 1 |
| Peñarrubia Ponce, MJ | 1 |
| Ortiz de Solórzano Aurusa, J | 1 |
| Fernández Salazar, L | 1 |
| Yang, ZR | 1 |
| Bi, CF | 1 |
| Zhang, WY | 1 |
| Yang, QP | 2 |
| Liu, WP | 2 |
| Lipson, EJ | 1 |
| Bodell, MA | 1 |
| Kraus, ES | 1 |
| Sharfman, WH | 1 |
| Liu, QF | 1 |
| Wang, WH | 2 |
| Wang, SL | 2 |
| Liu, YP | 2 |
| Huang, WT | 1 |
| Lu, N | 1 |
| Zhou, LQ | 4 |
| Ouyang, H | 1 |
| Jin, J | 4 |
| Li, YX | 4 |
| Wang, Z | 1 |
| Luo, D | 1 |
| Xiao, H | 1 |
| Joshua Liao, D | 1 |
| Jin, JG | 1 |
| Goto, N | 1 |
| Tsurumi, H | 1 |
| Takemura, M | 1 |
| Matsumoto, T | 1 |
| Shibata, Y | 1 |
| Mabuchi, R | 1 |
| Nakamura, N | 1 |
| Nakamura, H | 1 |
| Yamada, T | 1 |
| Takami, T | 1 |
| Takeuchi, T | 1 |
| Moriwaki, H | 1 |
| Kikuchi, N | 1 |
| Nakayama, H | 1 |
| Yang, KW | 1 |
| Yu, W | 1 |
| Song, Y | 1 |
| Huang, LH | 1 |
| Han, WK | 1 |
| He, ZS | 1 |
| Mar, N | 1 |
| Digiuseppe, JA | 1 |
| Dailey, ME | 1 |
| Tuck, M | 1 |
| Lim, J | 1 |
| Lucar, J | 1 |
| Benator, D | 1 |
| Chi, KN | 1 |
| Higano, CS | 1 |
| Blumenstein, B | 1 |
| Ferrero, JM | 1 |
| Reeves, J | 1 |
| Feyerabend, S | 1 |
| Gravis, G | 1 |
| Merseburger, AS | 1 |
| Stenzl, A | 1 |
| Bergman, AM | 1 |
| Mukherjee, SD | 1 |
| Zalewski, P | 1 |
| Saad, F | 1 |
| Jacobs, C | 1 |
| Gleave, M | 1 |
| de Bono, JS | 1 |
| Zwick, C | 1 |
| Birkmann, J | 1 |
| Peter, N | 1 |
| Bodenstein, H | 1 |
| Fuchs, R | 1 |
| Hänel, M | 1 |
| Reiser, M | 1 |
| Hensel, M | 1 |
| Clemens, M | 1 |
| Zeynalova, S | 1 |
| Ziepert, M | 1 |
| Pfreundschuh, M | 1 |
| Boccardo, F | 1 |
| Rubagotti, A | 1 |
| Conti, G | 1 |
| Battaglia, M | 1 |
| Cruciani, G | 1 |
| Manganelli, A | 1 |
| Ricci, S | 1 |
| Lapini, A | 1 |
| Kato, H | 1 |
| Naganuma, T | 1 |
| Iizawa, Y | 1 |
| Kitagawa, M | 1 |
| Tanaka, M | 1 |
| Isaji, S | 1 |
| Li, YL | 1 |
| Tang, Y | 1 |
| Zhao, S | 1 |
| Zuo, Z | 1 |
| Yang, YH | 1 |
| Luo, TY | 1 |
| Zhai, LZ | 1 |
| Xiao, J | 1 |
| Fu, XH | 1 |
| Ye, S | 1 |
| Guo, CC | 1 |
| Huang, JJ | 1 |
| Tian, Y | 1 |
| Lin, HL | 1 |
| Lin, TY | 1 |
| Conrad, AL | 1 |
| Go, RS | 1 |
| Celkan, TT | 1 |
| Bariş, S | 1 |
| Ozdemir, N | 1 |
| Ozkan, A | 1 |
| Apak, H | 1 |
| Doğru, O | 1 |
| Karaman, S | 1 |
| Canbolat, A | 1 |
| Ozdil, M | 1 |
| Aki, H | 1 |
| Adaletli, I | 1 |
| Kurugoglu, S | 1 |
| Hallac, M | 1 |
| Yildiz, I | 1 |
| Simal, E | 1 |
| Hörndler, C | 1 |
| Porta, N | 1 |
| Baldellou, R | 1 |
| Fett, N | 1 |
| Liu, RH | 1 |
| Yang, H | 1 |
| Lang, RG | 1 |
| Liu, FF | 1 |
| Wang, XF | 1 |
| Jin, ZJ | 1 |
| Lü, AJ | 1 |
| Wang, Y | 1 |
| Fu, XL | 1 |
| Fu, L | 1 |
| Shikama, N | 1 |
| Oguchi, M | 1 |
| Isobe, K | 1 |
| Nakamura, K | 1 |
| Tamaki, Y | 1 |
| Hasegawa, M | 1 |
| Kodaira, T | 1 |
| Sasaki, S | 1 |
| Kagami, Y | 1 |
| Buckman, R | 1 |
| Sonpavde, G | 1 |
| Matveev, V | 1 |
| Burke, JM | 1 |
| Caton, JR | 1 |
| Fleming, MT | 1 |
| Hutson, TE | 1 |
| Galsky, MD | 1 |
| Berry, WR | 1 |
| Karlov, P | 1 |
| Holmlund, JT | 1 |
| Wood, BA | 1 |
| Brookes, M | 1 |
| Leopold, L | 1 |
| Schoenberger, SD | 1 |
| Kim, SJ | 1 |
| Lavin, P | 1 |
| Shah, BK | 1 |
| Shrestha, S | 1 |
| Li, M | 1 |
| Liu, CL | 1 |
| Wang, XY | 1 |
| Xue, XM | 1 |
| Gao, ZF | 1 |
| Yalin, Y | 1 |
| Pingzhang, T | 1 |
| Smith, GI | 1 |
| Ilankovan, V | 1 |
| Rivkin, SE | 8 |
| Green, SJ | 1 |
| Lew, D | 1 |
| Costanzi, JJ | 5 |
| Athens, JW | 2 |
| Osborne, CK | 8 |
| Vaughn, CB | 1 |
| Martino, S | 3 |
| De Frenza, N | 1 |
| Magni, M | 1 |
| Trebbi, G | 1 |
| Weiss, RB | 3 |
| Woolf, SH | 1 |
| Demakos, E | 1 |
| Holland, JF | 7 |
| Berry, DA | 1 |
| Falkson, G | 7 |
| Cirrincione, CT | 1 |
| Robbins, A | 1 |
| Bothun, S | 1 |
| Henderson, IC | 2 |
| Norton, L | 1 |
| Michau, TM | 1 |
| Proulx, DR | 1 |
| Rushton, SD | 1 |
| Olivry, T | 1 |
| Dunston, SM | 1 |
| Gilger, BC | 1 |
| Davidson, MG | 1 |
| Dieckmann, K | 1 |
| Pötter, R | 1 |
| Hofmann, J | 1 |
| Heinzl, H | 1 |
| Wagner, W | 1 |
| Schellong, G | 2 |
| Kraemer, DM | 1 |
| Weissinger, F | 1 |
| Reimer, P | 1 |
| Kunzmann, V | 1 |
| Rüdiger, T | 1 |
| Wilhelm, M | 1 |
| Fernández-Ruiz, E | 1 |
| Cabrerizo, M | 1 |
| Ortega, M | 1 |
| Blas, C | 1 |
| Llamas, P | 1 |
| Santos-Roncero, M | 1 |
| Nieto, S | 1 |
| Acevedo, A | 1 |
| Pérez, G | 1 |
| Nicolás, C | 1 |
| Fernández-Rañada, JM | 1 |
| Arranz, R | 1 |
| Gholam, D | 1 |
| Bibeau, F | 1 |
| El Weshi, A | 1 |
| Bosq, J | 1 |
| Ribrag, V | 1 |
| CONKLIN, EF | 1 |
| GOLDMAN, BS | 1 |
| PEARSON, FG | 1 |
| Tronnier, M | 1 |
| Merz, H | 1 |
| Coupland, SE | 1 |
| Gruber, G | 1 |
| Greiner, RH | 1 |
| Hlushchuk, R | 1 |
| Aebersold, DM | 1 |
| Altermatt, HJ | 1 |
| Berclaz, G | 1 |
| Djonov, V | 1 |
| Zhou, SY | 1 |
| Huang, DZ | 1 |
| Shi, YK | 1 |
| He, XH | 1 |
| Wu, YH | 1 |
| Yang, BY | 1 |
| Yong, WB | 1 |
| Zhu, J | 1 |
| Zheng, W | 1 |
| Zhang, YT | 1 |
| Wang, XP | 1 |
| Meng, SN | 1 |
| Agada, FO | 1 |
| Mistry, D | 1 |
| Grace, AR | 1 |
| Coatesworth, AP | 1 |
| Hobdy, EM | 1 |
| Shafi, NQ | 1 |
| Kummar, S | 1 |
| Wendling, D | 1 |
| Aubin, F | 1 |
| Yao, B | 1 |
| Fang, H | 1 |
| Liu, XF | 2 |
| Yu, ZH | 2 |
| Kim, JH | 1 |
| Jang, JH | 1 |
| Koh, SB | 1 |
| Cervigón, I | 1 |
| Gargallo, AB | 1 |
| Bahillo, C | 1 |
| Martínez-Amo, JL | 1 |
| Orradre, JL | 1 |
| Muñoz-Madero, V | 1 |
| García-Almagro, D | 1 |
| Song, YW | 1 |
| Han, JZ | 1 |
| Tan, WY | 1 |
| Hu, DS | 1 |
| Zeng, FY | 1 |
| Song, QB | 1 |
| Hu, S | 1 |
| Wei, L | 1 |
| Droz, JP | 1 |
| Chaladaj, A | 1 |
| Wade, PM | 1 |
| Smith, RE | 1 |
| Johns, ME | 1 |
| Tormey, DC | 7 |
| Weinberg, VE | 1 |
| Glidewell, OJ | 1 |
| Perloff, M | 1 |
| Falkson, HC | 3 |
| Henry, PH | 1 |
| Leone, LA | 1 |
| Carbone, PP | 2 |
| Wood, WC | 2 |
| Knight, WA | 1 |
| Glucksberg, H | 4 |
| Foulkes, MA | 1 |
| Stephens, RL | 1 |
| O'Bryan, RM | 3 |
| Sledge, GW | 1 |
| Gelber, RD | 5 |
| Taylor, SG | 2 |
| Gray, R | 5 |
| Olson, JE | 2 |
| Jones, SE | 2 |
| Moon, TE | 2 |
| Tormey, C | 1 |
| Foulkes, M | 1 |
| Brambilla, C | 1 |
| Valagussa, P | 3 |
| Bonadonna, G | 3 |
| Goldhirsch, A | 6 |
| Smalley, RV | 1 |
| Bartolucci, AA | 1 |
| Moore, M | 1 |
| Vogel, C | 1 |
| Carpenter, J | 1 |
| Perez, CA | 1 |
| Velez-Garcia, E | 1 |
| Marcial, V | 1 |
| Lefante, J | 1 |
| Wittliff, J | 1 |
| Kolygin, BA | 1 |
| Kharatishvili, ZV | 1 |
| Chisesi, T | 1 |
| Ricciardi, O | 1 |
| Dal Fior, S | 1 |
| Cappellari, F | 1 |
| Pozza, F | 1 |
| Dini, E | 1 |
| Schoengen, A | 1 |
| Henney, JE | 1 |
| DeVita, VT | 1 |
| Feltkamp, H | 1 |
| Döhnert, G | 1 |
| Stock, W | 1 |
| Lang, R | 1 |
| Mies, R | 1 |
| Mödder, B | 1 |
| Thiele, KG | 1 |
| Rasmussen, S | 1 |
| Tranum, B | 1 |
| Gad-el-Mawla, N | 2 |
| Costanzi, J | 1 |
| Hoogstraten, B | 2 |
| Athens, J | 2 |
| Maloney, T | 2 |
| McCracken, J | 1 |
| Vaughn, C | 1 |
| von Rottkay, P | 1 |
| Lössl, HJ | 1 |
| Brunner, KW | 2 |
| Joss, R | 1 |
| Sonntag, RW | 1 |
| Tschopp, L | 1 |
| Meakin, JW | 2 |
| Glidewell, O | 2 |
| Cooper, RG | 2 |
| Trevor, PB | 1 |
| Saunders, GK | 1 |
| Waldron, DR | 1 |
| Leib, MS | 1 |
| Budd, GT | 1 |
| Green, S | 6 |
| Abeloff, MD | 4 |
| Rinehart, JJ | 1 |
| Hahn, R | 1 |
| Harris, J | 1 |
| Tormey, D | 1 |
| O'Sullivan, J | 3 |
| Castiglione-Gertsch, M | 1 |
| Johnsen, C | 1 |
| Rudenstam, CM | 1 |
| Collins, J | 1 |
| Lindtner, J | 1 |
| Hacking, A | 1 |
| Cortes-Funes, H | 1 |
| Forbes, J | 1 |
| Metch, B | 3 |
| Cruz, AB | 2 |
| Jewell, WR | 3 |
| Farrar, WB | 2 |
| Minton, JP | 2 |
| de Graaf, H | 1 |
| Willemse, PH | 2 |
| de Vries, EG | 2 |
| Sleijfer, DT | 2 |
| Mulder, PO | 2 |
| van der Graaf, WT | 1 |
| Smit Sibinga, CT | 1 |
| van der Ploeg, E | 2 |
| Dolsma, WV | 2 |
| Mulder, NH | 2 |
| Lobo-Sanahuja, F | 1 |
| García, I | 1 |
| Barrantes, JC | 1 |
| Barrantes, M | 1 |
| Jiménez, R | 1 |
| Argüello, A | 1 |
| Altman, SJ | 1 |
| Gilchrist, K | 1 |
| Lewis, JJ | 1 |
| Healey, JH | 1 |
| Huvos, AG | 1 |
| Burt, M | 1 |
| Sauer, R | 1 |
| Martus, P | 1 |
| Falk, S | 1 |
| Walther, F | 1 |
| Denk, R | 1 |
| Volgger, B | 1 |
| Marth, C | 1 |
| Zeimet, A | 1 |
| Müller-Holzner, E | 1 |
| Ruth, N | 1 |
| Dapunt, O | 1 |
| Cameron, DA | 1 |
| Anderson, ED | 1 |
| Levack, P | 1 |
| Hawkins, RA | 1 |
| Anderson, TJ | 1 |
| Leonard, RC | 1 |
| Forrest, AP | 1 |
| Chetty, U | 1 |
| Hughes, RG | 1 |
| Morgan, DW | 1 |
| Mehta, RR | 1 |
| McDermott, JH | 1 |
| Hieken, TJ | 1 |
| Marler, KC | 1 |
| Patel, MK | 1 |
| Wild, LD | 1 |
| Das Gupta, TK | 1 |
| Osoba, D | 1 |
| Tannock, IF | 1 |
| Ernst, DS | 1 |
| Neville, AJ | 1 |
| Ishiguro, K | 1 |
| Kojima, K | 1 |
| Tsubota, M | 1 |
| Seki, M | 1 |
| Kurumaya, H | 1 |
| Charton-Bain, MC | 1 |
| Lelong, B | 1 |
| Bouabdallah, R | 1 |
| Dubus, P | 1 |
| Merlio, JP | 1 |
| Hassoun, J | 1 |
| Xerri, L | 1 |
| Brito, RA | 1 |
| Valero, V | 1 |
| Buzdar, AU | 2 |
| Booser, DJ | 1 |
| Ames, F | 1 |
| Strom, E | 1 |
| Ross, M | 1 |
| Theriault, RL | 1 |
| Frye, D | 1 |
| Kau, SW | 1 |
| Asmar, L | 1 |
| McNeese, M | 1 |
| Singletary, SE | 1 |
| Hortobagyi, GN | 2 |
| Page, DL | 1 |
| Allred, DC | 1 |
| Dressler, LG | 1 |
| Hatfield, AK | 1 |
| Robert, NJ | 1 |
| Just-Viera, JO | 1 |
| Silva, JE | 1 |
| O'Neill, TJ | 1 |
| Kardinal, CG | 1 |
| Tierney, LM | 1 |
| Merrin, CE | 1 |
| Morris, D | 1 |
| Aisner, J | 1 |
| Elias, EG | 1 |
| Wiernik, PH | 1 |
| Desforges, JF | 1 |
| Rutherford, CJ | 1 |
| Dietz, R | 1 |
| Tkocz, HJ | 1 |
| Carey, RW | 1 |
| Sohier, WD | 1 |
| Kaufman, S | 1 |
| Weitzman, SA | 1 |
| Kelley, RM | 1 |
| Lew, RA | 1 |
| Halpern, E | 1 |
| Sanz, MA | 1 |
| Mayans, J | 1 |
| Martínez, J | 1 |
| Caballero, O | 1 |
| Marty, ML | 1 |
| Allt, WE | 1 |
| Beale, FA | 1 |
| Bush, RS | 1 |
| Clark, RM | 1 |
| Fitzpatrick, PJ | 1 |
| Hawkins, NV | 1 |
| Jenkin, RD | 1 |
| Pringle, JF | 1 |
| Reid, JG | 1 |
| Rider, WD | 1 |
| Plesnicar, S | 1 |
| Sumi-Kriznik, T | 1 |
| Golouh, R | 1 |
| Vanderploeg, DE | 1 |
| Gallmeier, WM | 1 |
| Bruntsch, U | 1 |
| Schmidt, CG | 1 |
| Feldman, ER | 1 |
| Eagan, RT | 1 |
| Schaid, DJ | 1 |
| Breda, E | 1 |
| Temperilli, L | 1 |
| Albain, KS | 1 |
| LeBlanc, M | 1 |
| Rivkin, S | 2 |
| Ruskoné-Fourmestraux, A | 1 |
| Pescatore, P | 1 |
| Rambaud, JC | 1 |
| Lavergne, A | 1 |
| Colombel, JF | 1 |
| Eugène, C | 1 |
| Modigliani, R | 1 |
| Lemaire, R | 1 |
| Gendre, JP | 1 |
| Galian, A | 1 |
| Mansour, EG | 2 |
| Eudey, L | 1 |
| Shatila, AH | 2 |
| Gilchrist, KW | 2 |
| Cooper, MR | 3 |
| Straus, DJ | 1 |
| Gaynor, JJ | 1 |
| Myers, J | 1 |
| Merke, DP | 1 |
| Caravelli, J | 1 |
| Chapman, D | 1 |
| Yahalom, J | 2 |
| Clarkson, BD | 1 |
| Solidoro, A | 1 |
| Payet, C | 1 |
| Sanchez-Lihon, J | 1 |
| Montalbetti, JA | 1 |
| Kaaden, R | 1 |
| Zwack, K | 1 |
| Wienbeck, M | 1 |
| Klotz, E | 1 |
| Hoskins, PJ | 1 |
| Ng, V | 1 |
| Spinelli, JJ | 1 |
| Klimo, P | 1 |
| Connors, JM | 1 |
| McLaughlin, P | 1 |
| Fuller, L | 1 |
| Redman, J | 1 |
| Hagemeister, F | 1 |
| Durr, E | 1 |
| Allen, P | 1 |
| Holmes, L | 1 |
| Velasquez, W | 1 |
| Swan, F | 1 |
| Cabanillas, F | 1 |
| Santoro, A | 1 |
| Zanini, M | 1 |
| Zucali, R | 1 |
| Negretti, E | 1 |
| McMaster, ML | 1 |
| Greer, JP | 1 |
| Wolff, SN | 1 |
| Johnson, DH | 1 |
| Greco, FA | 1 |
| Stein, RS | 1 |
| Cousar, JB | 1 |
| Flexner, JM | 1 |
| Hainsworth, JD | 1 |
| Winter, SS | 1 |
| Duncan, MH | 1 |
| Foucar, E | 1 |
| McConnell, TS | 1 |
| Cartwright, KC | 1 |
| Levine, MN | 1 |
| Bramwell, V | 1 |
| Abu-Zahra, H | 1 |
| Goodyear, MD | 1 |
| Arnold, A | 1 |
| Findlay, B | 1 |
| Skillings, J | 1 |
| Gent, M | 1 |
| Lichtman, SM | 1 |
| Budman, D | 1 |
| Bosworth, H | 1 |
| Allen, S | 1 |
| Schulman, P | 1 |
| Weiselberg, L | 1 |
| Weiss, R | 1 |
| Lehrman, D | 1 |
| Vinciguerra, V | 1 |
| Wolberg, WH | 1 |
| Gillchrist, KW | 1 |
| Harris, JE | 1 |
| Camoriano, JK | 1 |
| Loprinzi, CL | 1 |
| Ingle, JN | 2 |
| Therneau, TM | 1 |
| Krook, JE | 2 |
| Veeder, MH | 1 |
| Içli, F | 1 |
| Dinçol, D | 1 |
| Isikman, E | 1 |
| Unal, M | 1 |
| Castiglione, M | 2 |
| Sentis, HJ | 1 |
| Willemze, R | 1 |
| Van Vloten, WA | 1 |
| Nunnink, JC | 1 |
| Krusinski, PA | 1 |
| Yates, JW | 1 |
| Behrendt, H | 1 |
| Van Bunningen, BN | 1 |
| Van Leeuwen, EF | 1 |
| Lawlor, E | 1 |
| O'Briain, DS | 1 |
| Finn, T | 1 |
| Ward, R | 1 |
| Rogers, FM | 1 |
| O'Brien, AA | 1 |
| Daly, PA | 1 |
| Cabanillas, FF | 1 |
| Gulati, S | 1 |
| Shank, B | 1 |
| Clarkson, B | 1 |
| Fuks, Z | 1 |
| Apple, JS | 1 |
| Paulson, DF | 1 |
| Baber, C | 1 |
| Putman, CE | 1 |
| Everson, LK | 1 |
| Wieand, HS | 1 |
| Cullinan, SA | 1 |
| Wold, LE | 1 |
| Hagen, JB | 1 |
| Martin, JK | 1 |
| Fitzgibbons, RG | 1 |
| Foley, JF | 1 |
| Constanzi, JJ | 1 |
| Fowble, B | 1 |
| Glick, J | 1 |
| Goodman, R | 1 |
| Smith, TL | 1 |
| Kau, S | 1 |
| Marcus, C | 1 |
| Holmes, FA | 1 |
| Hug, V | 1 |
| Fraschini, G | 1 |
| Ames, FC | 1 |
| Martin, RG | 1 |
| Kanda, H | 1 |
| Hachisuka, K | 1 |
| Yamaguchi, A | 1 |
| Isogai, M | 1 |
| Kato, J | 1 |
| Matsushita, M | 1 |
| Oda, T | 1 |
| Harakawa, I | 1 |
| Kuze, S | 1 |
| Mayumi, T | 1 |
| Brämswig, JH | 1 |
| Schwarze, EW | 1 |
| Wannenmacher, M | 1 |
| Buzdar, A | 1 |
| Montague, E | 1 |
| Powles, T | 1 |
| Mauch, P | 1 |
| Tarbell, N | 1 |
| Skarin, A | 1 |
| Rosenthal, D | 1 |
| Weinstein, H | 1 |
| Mead, GM | 1 |
| Sweetenham, JW | 1 |
| Ewins, DL | 1 |
| Furlong, M | 1 |
| Lowes, JA | 1 |
| Huntington, MO | 1 |
| Kalish, LA | 1 |
| Cummings, F | 1 |
| Bennett, JM | 1 |
| Takenaka, T | 1 |
| Minato, K | 1 |
| Nagai, M | 1 |
| Kitahara, T | 1 |
| Shimoyama, M | 1 |
| Sakano, T | 1 |
| Konda, C | 1 |
| Laurens, A | 1 |
| Antoine, HM | 1 |
| Du Bourget, F | 1 |
| Juillet, Y | 1 |
| Hiltenbrand, C | 1 |
| Sievers, DB | 1 |
| Donovan, AJ | 1 |
| Tashima, CK | 1 |
| Lokich, JJ | 1 |
| Pinkus, GS | 1 |
| Moloney, WC | 1 |
| Morgenfeld, MC | 1 |
| Helft, F | 1 |
| Bomchil, G | 1 |
| Palva, T | 1 |
| Palva, A | 1 |
| Dammert, K | 1 |
| Karma, P | 1 |
| Le Bourgeois, JP | 1 |
| Delobel, J | 1 |
| Lewis, MB | 1 |
| Nunes, LB | 1 |
| Powell, DE | 1 |
| Shnider, BI | 1 |
| Lewinsky, BS | 1 |
| Grigor, KM | 1 |
| Symington, T | 1 |
| Neville, AM | 1 |
| Kingdon, HS | 1 |
| Baron, JM | 1 |
| Byrne, GE | 1 |
| Rappaport, H | 1 |
| Walther, H | 1 |
| Mullins, GM | 1 |
| Lenhard, RE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter Clinical Study With Early Treatment Intensification In Patients With High- Risk Hodgkin Lymphoma, Identified As FDG-PET Scan Positive After 2 Conventional ABVD Courses[NCT00795613] | Phase 2 | 450 participants (Anticipated) | Interventional | 2008-06-30 | Active, not recruiting | ||
| [NCT00265018] | Phase 3 | 1,370 participants (Actual) | Interventional | 1998-05-31 | Completed | ||
| A Randomized Phase 3 Study Comparing Standard First-Line Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With Custirsen (OGX-011) in Men With Metastatic Castrate Resistant Prostate Cancer[NCT01188187] | Phase 3 | 1,022 participants (Actual) | Interventional | 2010-11-30 | Completed | ||
| A Randomized, Double Blind, Placebo-controlled Multiple-center Phase III Trial of Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression[NCT01977209] | Phase 3 | 204 participants (Anticipated) | Interventional | 2013-09-30 | Recruiting | ||
| The Effects of Exercise Training on Tumor Vascularity and Response to Neoadjuvant Therapy in Operable Breast Cancer: A Phase I-II Study[NCT00405678] | Phase 1/Phase 2 | 23 participants (Actual) | Interventional | 2006-09-30 | Completed | ||
| Double Lung Transplant REgistry Aimed for Lung-limited Malignancies (DREAM) - a Prospective Observational Registry Study for Patients Undergoing Lung Transplantation for Medically Refractory Cancers Confined to the Lungs[NCT05671887] | 125 participants (Anticipated) | Observational [Patient Registry] | 2022-11-16 | Recruiting | |||
| Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment: a Prospective Cohort Study on Patients Affected by Breast Cancer[NCT03210441] | 204 participants (Anticipated) | Observational | 2014-05-06 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for prednisone and Lymph Node Metastasis
| Article | Year |
|---|---|
Idiopathic retroperitoneal fibrosis with endometrial cancer: a case report and literature review.
Topics: Endometrial Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middl | 2022 |
Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Ducts; Biopsy; Chemotherapy, Adjuvant; Cholangi | 2017 |
Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2009 |
Multicentric reticulohistiocytosis with dermatomyositis-like features: a more common disease presentation than previously thought.
Topics: Alendronate; Antineoplastic Protocols; Arthritis; Breast Neoplasms; Combined Modality Therapy; Derma | 2011 |
Primary breast lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dis | 2003 |
[Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child; Cli | 2004 |
Management of metastatic prostate cancer: the crucial role of geriatric assessment.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Docet | 2008 |
Response of esthesioneuroblastoma to chemotherapy. Report of five cases and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1984 |
Multimodal treatment of primary breast carcinoma: analysis of accomplishments and problem areas.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Estrog | 1981 |
[Isolated tumor of the rectum as primary manifestation of Burkitt lymphoma (author's transl)].
Topics: Adult; Burkitt Lymphoma; Doxorubicin; Female; Humans; Lymphatic Metastasis; Prednisone; Prognosis; R | 1981 |
[Metastatic malignant melanoma in treated non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Humans; Lymph Nodes; Lymphatic | 1996 |
[Hepatic MALT lymphoma disclosing a nodal extension].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Hepatitis B, | 2000 |
[The state of hormone and chemotherapy in breast neoplasms].
Topics: Androgens; Brain Neoplasms; Breast Neoplasms; Castration; Cyclophosphamide; Doxorubicin; Drug Therap | 1978 |
[Digestive lymphomatous polyposis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Gastrointesti | 1992 |
60 trials available for prednisone and Lymph Node Metastasis
| Article | Year |
|---|---|
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Tria
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2018 |
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherap | 2018 |
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (
Topics: Aged; Androgen Antagonists; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antineoplastic Com | 2013 |
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dise | 2017 |
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP r
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cycl | 2008 |
Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trial.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neopla | 2008 |
A long-term follow-up study of prospective 80%-dose CHOP followed by involved-field radiotherapy in elderly lymphoma patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-F | 2011 |
Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neopla | 2012 |
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Axil | 2003 |
Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cause of Deat | 2003 |
Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Co | 1984 |
A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; BCG Vaccine; Breast Neoplasms; | 1983 |
Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: preliminary results--the ECOG experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1983 |
Cancer and Leukemia Group B adjuvant chemotherapy trials in postmastectomy breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1983 |
Adjuvant therapy of breast cancer: the Southwest Oncology Group experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1983 |
Breast cancer 1984: state of the art.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Tr | 1984 |
Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Co | 1984 |
Postmenopausal node-positive comparison of observation with CMFP and CMPF + tamoxifen adjuvant therapy: an Eastern Cooperative Oncology Group trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Co | 1984 |
The use of a natural history data base to compare outcome among several trials of adjuvant chemotherapy for stage II breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1984 |
Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Clinical Trial | 1984 |
Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1984 |
Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Co | 1984 |
Southeastern Cancer Study Group: breast cancer studies 1972-1982.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabin | 1983 |
Multimodal treatment of primary breast carcinoma: analysis of accomplishments and problem areas.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Estrog | 1981 |
Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study.
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Flu | 1982 |
Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chi-Square Distributi | 1995 |
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemother | 1994 |
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ch | 1994 |
Stage III abdominal non-Hodgkin's lymphoma in Costa Rican children: comparison of two consecutive trials of treatment.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasm | 1994 |
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 1993 |
Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosp | 1993 |
Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chi-Square Distribution; Combined | 1996 |
[Sequencing of chemotherapy and radiotherapy following breast-preserving treatment of breast carcinoma].
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alky | 1996 |
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Axi | 1997 |
Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocol | 1999 |
Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dis | 2001 |
Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192).
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosp | 2001 |
Treatment of early breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug The | 1978 |
[Chemotherapy of metastasizing breast cancers. Indications and results].
Topics: Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Fema | 1975 |
Chemotherapy versus observation in high-risk node-negative breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Com | 1992 |
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1990 |
Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; C | 1991 |
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1991 |
The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosp | 1992 |
Late effects of adjuvant oophorectomy and chemotherapy upon premenopausal breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Mo | 1990 |
Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administrat | 1990 |
Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality The | 1990 |
Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Cause of Death; Combined Modality Therapy; Female; Follow | 1990 |
Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; C | 1989 |
Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1989 |
Chemotherapy with or without oophorectomy in high-risk premenopausal patients with operable breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials | 1985 |
A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials | 1985 |
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; | 1989 |
Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1988 |
Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1988 |
An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studies.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1988 |
Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1987 |
A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; C | 1986 |
Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1985 |
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1985 |
116 other studies available for prednisone and Lymph Node Metastasis
| Article | Year |
|---|---|
Multiple masses on the face of a 58-year-old woman.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnosis, Differential; D | 2020 |
Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort.
Topics: Aged; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Docet | 2019 |
Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome.
Topics: Abiraterone Acetate; Administration, Oral; Aged; Aged, 80 and over; Alanine Transaminase; Antineopla | 2020 |
Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Hum | 2020 |
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androstenes; Benzamides; Biomarkers, Tumor; Bone Neop | 2021 |
Uveitis induced by programmed cell death protein 1 inhibitor therapy with nivolumab in metastatic melanoma patient.
Topics: Administration, Ophthalmic; Antibodies, Monoclonal; Antineoplastic Agents; Betamethasone; Female; Gl | 2017 |
Nivolumab-induced polyarthritis.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antineoplastic Agents; Bursitis; Carcinoma, Non-Sm | 2017 |
Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma.
Topics: Administration, Oral; Administration, Topical; Aged, 80 and over; Antibodies, Monoclonal, Humanized; | 2018 |
Histologic transformation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; | 2013 |
[Synchronic MALT lymphoma and carcinoid tumor of the ileum].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomar | 2014 |
[Diffuse large B-cell lymphoma of testis: a clinicopathologic and immunophenotypic study of 58 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2013 |
Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Dacarbazine; Drug Adminis | 2014 |
Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy | 2014 |
Case report: metastases from thyroid and nasopharyngeal carcinomas in the same lymph node following chemotherapy for mantle cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Papillary; Cyclophospha | 2015 |
High-dose methylprednisolone is effective in treating radiation-induced refractory haemorrhagic cystitis.
Topics: Aluminum Oxide; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Com | 2014 |
Serum soluble tumor necrosis factor receptor 1 level is associated with the outcome of diffuse large B-cell lymphoma patients treated with the CHOP or R-CHOP regimen.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2014 |
Cryptogenic organising pneumonia after radiotherapy.
Topics: Adrenal Cortex Hormones; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Female; Humans; | 2014 |
[Predictor analysis of PSA response of docetaxel combined with prednisone in the treatment of metastatic castration resistant prostate cancer].
Topics: Disease Progression; Docetaxel; Humans; Lymphatic Metastasis; Male; Neoplasm Grading; Prednisone; Pr | 2015 |
Rubinstein-Taybi syndrome - a window into follicular lymphoma biology.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CREB-Binding Protein; Cyclophosphamide; DNA M | 2016 |
Anaplastic large cell lymphoma masquerading as osteomyelitis of the shoulder: an uncommon presentation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Diagnosis, Differe | 2016 |
Primary non-Hodgkin's lymphoma of the gallbladder diagnosed by laparoscopic cholecystectomy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2008 |
[Small cell variant of peripheral T-cell lymphoma, not otherwise specified: a clinicopathologic and immunophenotypic analysis].
Topics: 12E7 Antigen; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex | 2009 |
[Clinical features and prognosis of mucosa-associated lymphoid tissue lymphoma: a report of 90 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-F | 2009 |
Treatment of pediatric Burkitt lymphoma in Turkey.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biops | 2010 |
[Primary cutaneous CD30+ large T-Cell lymphoma with lymph node and cerebral metastases].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arm; Brain Neoplasms; Cyclophosph | 2010 |
[Primary lymphoma of breast: a clinicopathologic and prognostic study of 40 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD20; Antineoplastic Combined Chemotherapy Pro | 2011 |
Metronomic cyclophosphamide and methotrexate for breast cancer: enhanced efficacy by adding dalteparin and low-dose prednisone?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality T | 2011 |
Paraneoplastic optic neuropathy from cutaneous melanoma detected by positron emission tomographic and computed tomographic scanning.
Topics: Aged; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Lymph Node Excision; Lymph | 2012 |
Durable complete remission with abiraterone in castration resistant metastatic prostate cancer.
Topics: Adenocarcinoma; Androstenes; Androstenols; Antineoplastic Agents, Hormonal; Castration; Humans; Lymp | 2013 |
[Clinical significance of bcl-2 protein expression and classification algorithm in diffuse large B-cell lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Combined Chemotherapy Protoco | 2012 |
Management and outcome of cervical lymph node metastases of unknown primary sites: a retrospective study.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; | 2002 |
[Primary lymphoma of the uterus. A case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 2003 |
Intraocular extramedullary plasmacytoma in a cat.
Topics: Animals; Antineoplastic Agents; Blindness; Cat Diseases; Cats; Drug Therapy, Combination; Eye Injuri | 2003 |
Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
Topics: Adolescent; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Pres | 2003 |
Female patient with a history of Hashimoto's thyroiditis, diagnosed with MALT lymphoma of both breasts.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Breast Neoplasms; Cyclophospham | 2003 |
High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Disease- | 2003 |
SOME UNUSUAL COMPLICATIONS OF METASTATIC CARCINOMA OF THE BREAST.
Topics: Breast Neoplasms; Esophageal Diseases; Esophageal Neoplasms; Esophageal Stenosis; Gastrointestinal H | 1964 |
MALIGNANT PERICARDIAL EFFUSION. REVIEW OF HOSPITAL EXPERIENCE AND REPORT OF A CASE SUCCESSFULLY TREATED BY TALC POUDRAGE.
Topics: Breast Neoplasms; Cardiac Surgical Procedures; Cardiac Tamponade; Drug Therapy; Exudates and Transud | 1965 |
[Anaplastic large cell lymphoma and keratoacanthoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Follow-Up Studi | 2004 |
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherap | 2004 |
[Clinicopathologic features of primary thyroid lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva | 2005 |
[Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2005 |
Large B-cell non-Hodgkin's lymphoma presenting as a laryngeal cyst.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2005 |
Prostate cancer metastasis to supraclavicular lymph node.
Topics: Acid Phosphatase; Adenocarcinoma; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Prot | 2004 |
Metastatic malignant melanoma in a patient taking interleukin-1 receptor antagonist.
Topics: Aged; Antimalarials; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Interleukin 1 Recepto | 2006 |
[Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Topics: Adolescent; Adult; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 2006 |
A case of neurolymphomatosis involving cranial nerves: MRI and fusion PET-CT findings.
Topics: Aged; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cranial Nerve N | 2006 |
[Merkel cell carcinoma in a patient with chronic lymphocytic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Cyclophosphamide; Diagnosis, | 2006 |
[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 2007 |
Ludwig Breast Cancer trials LBCS III and IV: adjuvant endocrine treatment in postmenopausal patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Combined Modalit | 1984 |
[Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
Topics: Age Factors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophos | 1983 |
Treatment of early stage Hodgkin's disease with radiation therapy plus short-cycle (3 MOPP) adjuvant chemotherapy.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Evaluation S | 1983 |
[Chemotherapy of non-Hodgkin lymphomas].
Topics: Adult; Burkitt Lymphoma; Child; Cyclophosphamide; Drug Therapy, Combination; Humans; Leukemia, Hairy | 1980 |
[Combination of three therapy methods (operation-radiotherapy-chemotherapy) in case of mammary carcinoma with lymph node metastases].
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; | 1982 |
[Results of, and indications for adjuvant chemotherapy in breast cancer].
Topics: Adult; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; | 1981 |
Is there a place for adjuvant endocrine therapy of breast cancer?
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Castration; Drug Therapy, Combination; Female; Human | 1980 |
Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; F | 1980 |
Metastatic extramedullary plasmacytoma of the colon and rectum in a dog.
Topics: Animals; Biopsy, Needle; Blood Protein Electrophoresis; Chemotherapy, Adjuvant; Colonic Neoplasms; D | 1993 |
Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms | 1994 |
Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms | 1993 |
Benign giant-cell tumor of bone with metastasis to mediastinal lymph nodes. A case report of resection facilitated with use of steroids.
Topics: Bone Neoplasms; Combined Modality Therapy; Giant Cell Tumor of Bone; Glucocorticoids; Humans; Lympha | 1996 |
Fulminant course of a microinvasive vulvar carcinoma in an immunosuppressed woman.
Topics: Adult; Azathioprine; Carcinogens; Carcinoma in Situ; Carcinoma, Squamous Cell; Condylomata Acuminata | 1997 |
B-cell lymphoma with extensive cutaneous involvement presenting to the ENT surgeon.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 1998 |
Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor | 1998 |
[Malignant cardiac lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Ther | 2000 |
Esophageal carcinoma. The value of staging in long-term survival.
Topics: Administration, Oral; Cyclophosphamide; Esophageal Neoplasms; Esophagus; Female; Fluorouracil; Follo | 1975 |
Reversible interstitial pneumonitis associated with low dose bleomycin.
Topics: Abdominal Neoplasms; Bleomycin; Doxorubicin; Female; Humans; Lymphatic Metastasis; Lymphoma, Large B | 1975 |
Evaluation and treatment of non-seminomatous testicular tumors: a practical approach.
Topics: Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Humans; Lung Neopla | 1979 |
Mastectomy as an adjunct to combination chemotherapy.
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Int | 1978 |
Management of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lympha | 1979 |
[The period of time between operation and irradiation of a mamma carcinoma and its cytostatic treatment (author's transl)].
Topics: Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; | 1979 |
5-drug adjuvant chemotherapy for breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluoro | 1979 |
[Extraskeletal manifestations of unusual localization in a case of myeloma (author's transl)].
Topics: Female; Humans; Immunoglobulin G; Lymphatic Metastasis; Melphalan; Middle Aged; Multiple Myeloma; Ne | 1979 |
Adjuvant chemotherapy of breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; F | 1979 |
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
Topics: Adult; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Menopause; Middle Aged; Ovary; Predni | 1978 |
Abdominal lymphoma with alpha-heavy chain disease.
Topics: Abdominal Neoplasms; Adult; Autopsy; Cyclophosphamide; Heavy Chain Disease; Humans; Immunoglobulin a | 1975 |
Dermatomyositis and Malignancy.
Topics: Breast Neoplasms; Dermatomyositis; Female; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Pr | 1977 |
Therapy of primary breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Lymphatic Metasta | 1977 |
Editorial: Major advance in breast-cancer therapy.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil | 1976 |
Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: comparison of clinical manifestations, chemotherapeutic responses, and prognosis.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Age Factors; Aged; Antineoplastic Combin | 1992 |
[Intestinal lymphoma. A report of 2 cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colectomy; Colonic Neoplasms; Combined Mo | 1992 |
Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Fem | 1992 |
Gastric lymphomas: chemotherapy as a primary treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 1990 |
[Icteric cholestasis as an early symptom in Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cholestasis; Cyclophospham | 1990 |
Prognostic variables in patients with diffuse large-cell lymphoma treated with MACOP-B.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1991 |
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine | 1991 |
Childhood Ki-1 lymphoma: presentation as a buttock mass.
Topics: Aneuploidy; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomar | 1991 |
Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplas | 1991 |
Adjuvant chemotherapy and scar irradiation in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1990 |
Systemic polychemotherapy in patients with mycosis fungoides and lymph node involvement: a follow-up study of 17 patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Follow-Up Studies; H | 1985 |
Multicentric reticulohistiocytosis and cancer: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arthritis; Breast Neoplasms; Carcinoma, Intraductal, | 1985 |
Treatment of Hodgkin's disease in children with or without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 1987 |
The simultaneous presentation of peripheral T-cell lymphoma and hairy cell leukemia.
Topics: Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Antineoplastic C | 1987 |
Management of patients with low-grade follicular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Bone Neoplasms; Chromosomes, | 1989 |
Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1989 |
Advanced prostatic carcinoma: pulmonary manifestations.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Fluorouracil; Hum | 1985 |
The role of chemotherapy for node negative breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; | 1989 |
Radiotherapy for the prevention of local-regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphami | 1988 |
[Treatment of primary gastric lymphoma and factors that influence the prognosis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 1988 |
Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child, Presch | 1987 |
Intestinal cryptosporidiosis: a complication of cancer treatment.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Combin | 1986 |
Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Combined | 1985 |
[The significance of reinduction chemotherapy with adriamycin for relapsed non-Hodgkin's lymphoma of Waldeyer's ring].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; | 1985 |
[Chylous ascites and chylothorax, rare complications of Hodgkin's disease: do they represent a complication of the future?].
Topics: Adult; Antineoplastic Agents; Chylothorax; Chylous Ascites; Hodgkin Disease; Humans; Hydrazines; Lym | 1972 |
Palliative treatment of mammary cancer. Response of soft tissue, pleural and pulmonary disease.
Topics: Adrenalectomy; Adult; Age Factors; Aged; Breast Neoplasms; Castration; Cyclophosphamide; Dexamethaso | 1973 |
Association of malignant melanoma and malignant lymphoma.
Topics: Biopsy; Cyclophosphamide; Lymphatic Metastasis; Lymphoma; Melanoma; Neoplasm Metastasis; Neoplasm Re | 1973 |
Hodgkin's disease in the elderly.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Liver Neoplasms | 1974 |
[Different response of the superficial and deep lymph nodes to therapy in malignant lymphoreticulopathies].
Topics: Adult; Chlorambucil; Cyclophosphamide; Female; Humans; Leukemia, Lymphoid; Lymphatic Metastasis; Lym | 1968 |
Malignant lymphoma invading the facial nerve.
Topics: Child; Cochlear Nerve; Colon; Electric Stimulation; Facial Nerve; Facial Paralysis; Female; Humans; | 1974 |
[Chylous effusion during reticulosarcoma].
Topics: Abdominal Neoplasms; Chylothorax; Humans; Hydrazines; Inguinal Canal; Lumbosacral Region; Lymphatic | 1973 |
Extra-axial spread of medulloblastoma.
Topics: Autopsy; Brain Neoplasms; Carmustine; Cranial Fossa, Posterior; Femoral Neoplasms; Humans; Liver Neo | 1973 |
The clinical and pathologic features of "non-hormonal" adrenocortical tumors. Report of twenty new cases and review of the literature.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adult; Aged; Angiography; Antineoplast | 1974 |
Mlaignant histiocytosis. Results of combination vincristine-prednisone therapy.
Topics: Adolescent; Aged; Bone Marrow Examination; Bone Neoplasms; Cyclophosphamide; Female; Gastrointestina | 1970 |
[Hypercalcemia syndrome in bronchial carcinoma without skeletal metastasizing].
Topics: Bronchial Neoplasms; Carcinoma, Squamous Cell; Cardiac Glycosides; Female; Humans; Hypercalcemia; Hy | 1970 |
Digital clubbing in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Female; Fingers; Hodgkin Disease; Humans; Lung Neoplasms; | 1971 |